![Peter Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Huang
Directeur Technique/Scientifique/R&D chez
ZAI LAB LIMITED
Profil
Peter Huang is currently the Chief Scientific Officer at Zai Lab Ltd. Prior to this, he worked at Zentalis Pharmaceuticals, Inc. as the Senior Vice President-Discovery Research from 2015 to 2022.
He obtained a doctorate degree from Iowa State University.
Postes actifs de Peter Huang
| Sociétés | Poste | Début |
|---|---|---|
| ZAI LAB LIMITED | Directeur Technique/Scientifique/R&D | 08/11/2022 |
Anciens postes connus de Peter Huang
| Sociétés | Poste | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2022 |
Formation de Peter Huang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Choisissez Zonebourse 
